Kahn Allon, Yadav Anitha D, Harrison M Edwyn
Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA.
Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.
Case Rep Gastrointest Med. 2015;2015:591360. doi: 10.1155/2015/591360. Epub 2015 Aug 25.
IgG4-related disease is a relatively novel clinical entity whose gastrointestinal manifestations include type 1 autoimmune pancreatitis (AIP) and IgG4-associated sclerosing cholangitis. The presence of elevated serum IgG4 is suggestive but not essential for the diagnosis of type 1 AIP and is a pervasive feature of the proposed diagnostic criteria. The differential diagnosis of type 1 AIP includes malignant conditions, emphasizing the importance of a deliberate, comprehensive evaluation. Management of patients with a suggestive clinical presentation, but without serum IgG4 elevation, is difficult. Here we present three cases of IgG4-seronegative AIP and sclerosing cholangitis that responded to empiric steroid therapy and discuss approach considerations. These cases demonstrate the value of meticulous application of existing diagnostic algorithms to achieve a clinical diagnosis and avoid surgical intervention.
IgG4相关疾病是一种相对较新的临床实体,其胃肠道表现包括1型自身免疫性胰腺炎(AIP)和IgG4相关硬化性胆管炎。血清IgG4升高对1型AIP的诊断有提示作用,但并非必需,且是拟议诊断标准的一个普遍特征。1型AIP的鉴别诊断包括恶性疾病,这凸显了进行审慎、全面评估的重要性。对于临床表现提示但血清IgG4未升高的患者,治疗较为困难。在此,我们报告3例IgG4血清阴性的AIP和硬化性胆管炎病例,这些病例对经验性类固醇治疗有反应,并讨论了相关的处理考量。这些病例证明了严格应用现有诊断算法以实现临床诊断并避免手术干预的价值。